Aldeyra Reports Full Year 2016 Financial Results
LEXINGTON, MA--(Marketwired - March 30, 2017) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused primarily on the development of new products for inflammation, inborn errors of metabolism,…